Clinuvel Pharmaceuticals Ltd (CUV) — Net Asset Quality Index
Clinuvel Pharmaceuticals Ltd (CUV) has a Net Asset Quality Index of 92.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$269.70 Million minus total liabilities of AU$20.68 Million yields net assets of AU$249.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Clinuvel Pharmaceuticals Ltd (CUV) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Clinuvel Pharmaceuticals Ltd Net Asset Quality Index Over Time (2000–2025)
This chart shows how Clinuvel Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of December 2025, the index stands at 92.3%, representing net assets of AU$249.02 Million against total assets of AU$269.70 Million AUD. See working capital position of Clinuvel Pharmaceuticals Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Clinuvel Pharmaceuticals Ltd (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Clinuvel Pharmaceuticals Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CUV market cap overview.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.6% | AU$240.81 Million | AU$271.75 Million | AU$30.94 Million | ▲ +0.8 pp |
| 2024 | 87.8% | AU$203.01 Million | AU$231.12 Million | AU$28.11 Million | ▲ +3.2 pp |
| 2023 | 84.6% | AU$164.63 Million | AU$194.52 Million | AU$29.89 Million | ▼ -2.1 pp |
| 2022 | 86.7% | AU$125.56 Million | AU$144.81 Million | AU$19.25 Million | ▼ -4.2 pp |
| 2021 | 90.9% | AU$98.74 Million | AU$108.57 Million | AU$9.83 Million | ▲ +2.6 pp |
| 2020 | 88.4% | AU$72.07 Million | AU$81.54 Million | AU$9.48 Million | ▼ -3.3 pp |
| 2019 | 91.7% | AU$57.18 Million | AU$62.35 Million | AU$5.17 Million | ▼ -0.2 pp |
| 2018 | 91.9% | AU$39.42 Million | AU$42.90 Million | AU$3.49 Million | ▲ +2.9 pp |
| 2017 | 88.9% | AU$25.44 Million | AU$28.61 Million | AU$3.16 Million | ▲ +0.4 pp |
| 2016 | 88.6% | AU$17.83 Million | AU$20.14 Million | AU$2.30 Million | ▲ +6.4 pp |
| 2015 | 82.1% | AU$11.21 Million | AU$13.64 Million | AU$2.44 Million | ▼ -7.8 pp |
| 2014 | 89.9% | AU$15.43 Million | AU$17.15 Million | AU$1.73 Million | ▲ +2.4 pp |
| 2013 | 87.5% | AU$13.84 Million | AU$15.81 Million | AU$1.98 Million | ▲ +2.3 pp |
| 2012 | 85.3% | AU$13.64 Million | AU$16.00 Million | AU$2.36 Million | ▲ +3.9 pp |
| 2011 | 81.4% | AU$16.41 Million | AU$20.17 Million | AU$3.76 Million | ▼ -8.2 pp |
| 2010 | 89.6% | AU$26.43 Million | AU$29.51 Million | AU$3.08 Million | ▲ +0.5 pp |
| 2009 | 89.0% | AU$37.05 Million | AU$41.61 Million | AU$4.56 Million | ▼ -5.2 pp |
| 2008 | 94.3% | AU$51.81 Million | AU$54.97 Million | AU$3.16 Million | ▼ -2.2 pp |
| 2007 | 96.4% | AU$65.39 Million | AU$67.82 Million | AU$2.43 Million | ▲ +14.5 pp |
| 2006 | 81.9% | AU$13.99 Million | AU$17.07 Million | AU$3.08 Million | ▲ +7.8 pp |
| 2005 | 74.1% | AU$7.45 Million | AU$10.06 Million | AU$2.60 Million | ▼ -12.3 pp |
| 2004 | 86.4% | AU$8.85 Million | AU$10.25 Million | AU$1.39 Million | ▼ -7.0 pp |
| 2003 | 93.4% | AU$7.53 Million | AU$8.07 Million | AU$535.45K | ▼ -4.6 pp |
| 2002 | 98.0% | AU$10.31 Million | AU$10.52 Million | AU$210.83K | ▲ +0.3 pp |
| 2001 | 97.7% | AU$13.45 Million | AU$13.77 Million | AU$318.26K | ▼ -1.5 pp |
| 2000 | 99.2% | AU$15.32 Million | AU$15.44 Million | AU$123.54K | — |